This is an update of a previous story. To read the previous story, click here.
NEW YORK, March 15 (GenomeWeb News) - Waters Technologies has agreed to pay Applied Biosystems and MDS a total of $18.1 million to settle an ongoing patent dispute filed by ABI and MDS regarding an ion transmission technology for mass spectrometers, the companies said today.
The companies also settled a dispute concerning ABI's use of an electrospray technology for which Waters holds a patent, Waters' vice president of investor relations Gene Cassis said. The companies will now cross-license both disputed technologies in exc
The settlement with ABI and MDS, made through their ABI/MDS Sciex partnership, resolves two issues: The three companies had claimed infringement of each others' patents in the
A year ago, the US Court of Appeals for the Federal Circuit upheld a $52.6 million patent infringement award against Micromass UK, a wholly-owned subsidiary of Waters, for infringing US Patent No. 4,963,736, "Mass spectrometer and method and improved ion transmission".